SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · IEX Real-Time Price · USD
2.130
+0.040 (1.91%)
At close: Jul 19, 2024, 4:30 PM
2.210
+0.080 (3.76%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $80.47 million as of July 22, 2024. Its market cap has decreased by -23.21% in one year.
Market Cap
80.47M
Enterprise Value
14.92M
1-Year Change
-23.21%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has increased from $76.10M to $80.47M, an increase of 5.74%. That is a compound annual growth rate of 0.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 80.50M | -3.01% |
Dec 29, 2023 | 83.00M | 63.06% |
Dec 30, 2022 | 50.90M | -65.16% |
Dec 31, 2021 | 146.10M | 74.55% |
Dec 31, 2020 | 83.70M | 57.63% |
Dec 31, 2019 | 53.10M | 129.87% |
Dec 31, 2018 | 23.10M | -65.16% |
Dec 29, 2017 | 66.30M | -13.33% |
Dec 30, 2016 | 76.50M | -11.46% |
Dec 31, 2015 | 86.40M | 1.65% |
Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BioAtla | 81.80M |
Serina Therapeutics | 81.70M |
DBV Technologies | 80.83M |
Chimerix | 80.66M |
Protalix BioTherapeutics | 80.65M |
PMV Pharmaceuticals | 80.25M |
Ikena Oncology | 80.11M |
Nutriband | 79.90M |